BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lorenzo GD, Rea A, Carlomagno C, Pepe S, Palmieri G, Labianca R, Chirianni A, Stefano AD, Esposito V, Placido SD, Montesarchio V. Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: A phase II study. World J Gastroenterol 2007; 13(48): 6553-6557 [PMID: 18161926 DOI: 10.3748/wjg.v13.i48.6553]
URL: https://www.wjgnet.com/1948-5182/full/v13/i48/6553.htm
Number Citing Articles
1
Debra Wu, Douglas Vogus, Vinu Krishnan, Marta Broto, Anusha Pusuluri, Zongmin Zhao, Neha Kapate, Samir Mitragotri. Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant LiposomesPharmaceutics 2021; 13(1): 107 doi: 10.3390/pharmaceutics13010107